Delivery Order SPE2DB20D7061-SPE2DB24FSML0
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ondansetron ODT 4 mg tablets. The contract has a completion date of January 30, 2024 and a potential value of $5,983.56. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,076.86 contract is for the supply of Ondansetron ODT 4 mg tablets, with a period of performance through January 26, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order (DO) contract valued at $1,878.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 4 mg tablets. This DO is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between DLA and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $6,750.94, is for the supply of 4,564,073,710 units of the generic medication ondansetron ODT 4 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,721.02 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $9,280.48, is for the delivery of Ondansetron HCL 8 mg tablets and has a performance period through March 27, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,664.49 and a period of performance through February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is issued under a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,943,300 Ondansetron ODT 4 mg tablets. The delivery order is valued at $2,256.20 and has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,915.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB24FSML0Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical and medical supply distributor, to provide ondansetron ODT 4 mg tablets. The contract has a potential value of $6,134.10 and a performance period through February 15, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide these critical healthcare materials to military treatment programs and facilities worldwide. The contract awards do not include any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 2/14/24 |